CD8A and cancer: Recently, the CCL20-CCR6 axis has been known to promote cancer progression by enabling cancer cell migration and proliferation via CCL20 signalling also known as macrophage inflammatory protein40 and in CCC macrophages recruit Treg, CD8+ T and effector CD4+ T cells (Figure 2h).